Molecular modeling studies of atorvastatin analogues as HMGR inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2014-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2014.06.055PMID 25022881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microwave-assisted expeditious synthesis of 5-fluoroalkyl-3-(aryl/alkyl)-oxazolidin-2-ones

  2013cited by this paper
• Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking

  2012cited by this paper
• Synthesis of 1,3,5‐Trisubstituted [4‐tert‐Butyl 2‐(5,5‐difluoro‐2,2‐dimethyl‐6‐vinyl‐1,3‐dioxan‐4‐yl)acetate]pyrazoles via a Pd‐Catalyzed CH Activation

  2012cited by this paper
• Synthesis of γ,γ-difluoro-β-hydroxy-δ-lactones as new precursors of HMG-CoA reductase inhibitor

  2012cited by this paper
• Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distribution.

  2011cited by this paper
• Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies.

  2010cited by this paper
• Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.

  2008cited by this paper
• 3D QSAR and Molecular Docking Studies of Benzimidazole Derivatives as Hepatitis C Virus NS5B Polymerase Inhibitors

  2008cited by this paper
• Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia.

  2008cited by this paper
• Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase.

  2007cited by this paper
• Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.

  2007cited by this paper
• Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors.

  2007cited by this paper
• Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.

  2007cited by this paper
• Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-design.

  2007cited by this paper
• Risk for myopathy with statin therapy in high-risk patients.

  2003cited by this paper
• Statin-associated myopathy.

  2003cited by this paper
• Structural Mechanism for Statin Inhibition of HMG-CoA Reductase

  2001cited by this paper
• Crystal structure of the catalytic portion of human HMG‐CoA reductase: insights into regulation of activity and catalysis

  2000cited by this paper
• Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase.

  1999cited by this paper
• Photochemistry of substituted 4-halogenophenols: effect of a CN substituent

  1999cited by this paper
• Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

  1994cited by this paper
• Hypercholesterolaemia

  1990cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper
• Partial least squares analysis with cross‐validation for the two‐class problem: A Monte Carlo study

  1987cited by this paper
• Cholesterol and coronary heart disease. A new era.

  1986cited by this paper
• Multivariate Data Analysis in Chemistry

  1984cited by this paper
• Local interactions as a structure determinant for protein molecules: II.

  1979cited by this paper
• Local interactions as a structure determinant for protein molecules: III.

  1979cited by this paper
• Hydrophobic character of amino acid residues in globular proteins

  1978cited by this paper
• Acid catalysed hydrolysis of N-alkyl-4-chlorobenzamides. Part II.

  1975cited by this paper
• The interpretation of protein structures: estimation of static accessibility.

  1971cited by this paper

• Determination of the latent geometry of atorvastatin pharmacokinetics by transfer entropy to identify bottlenecks

  2025cites this paper
• Anticancer effect of bioactive compound Apparicine isolated from the Tabernaemontana divaricata on retinoblastoma cancer cell line (Y79) and in silico docking approaches

  2024cites this paper
• Predictive Modeling of HMG-CoA Reductase Inhibitory Activity and Design of New HMG-CoA Reductase Inhibitors

  2023cites this paper
• Computer-Aided and AILDE Approaches to Design Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors

  2022cites this paper
• Significance of stressor media on the stability of statins: a critical assessment

  2022cites this paper
• Copper Catalyzed Decarboxylative Functionalization of Ketoacids

  2021cites this paper
• Impact of the Difluoromethylene Group (CF2) in Organocatalyzed Acylative Kinetic Resolution of α,α-Difluorohydrins.

  2021cites this paper
• Enantioselective Synthesis of Acyclic Stereotriads Featuring Fluorinated Tetrasubstituted Stereocenters.

  2021cites this paper
• A Multi-Target Drug Designing for BTK, MMP9, Proteasome And TAK1 for the clinical treatment of Mantle Cell Lymphoma.

  2021cites this paper
• Bicyclo[1.1.1]Pentane as Phenyl Substituent in Atorvastatin Drug to improve Physicochemical Properties: Drug-likeness, DFT, Pharmacokinetics, Docking, and Molecular Dynamic Simulation

  2020cites this paper
• In silico studies of novel scaffold of thiazolidin-4-one derivatives as anti-Toxoplasma gondii agents by 2D/3D-QSAR, molecular docking, and molecular dynamics simulations

  2020influential citation
• Pharmacophore modelling, QSAR study, molecular docking and insilico ADME prediction of 1,2,3-triazole and pyrazolopyridones as DprE1 inhibitor antitubercular agents

  2020cites this paper
• QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents.

  2020cites this paper
• Investigation of pyrimidine analogues as xanthine oxidase inhibitors to treat of hyperuricemia and gout through combined QSAR techniques, molecular docking and molecular dynamics simulations

  2020cites this paper
• Rational in silico drug design of HIV-RT inhibitors through G-QSAR and molecular docking study of 4-arylthio and 4-aryloxy-3-iodopyridine-2(1-H)-one derivative

  2020cites this paper
• A Combined approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and in silico ADME/Tox prediction of 4-Arylthio & 4- Aryloxy-3- Iodopyridine-2(1H)-one analogs to identify potential Reverse Transcriptase inhibitor: Anti-HIV agents.

  2020cites this paper
• Investigation of MI-2 analogues as MALT1 inhibitors to treat of diffuse large B-Cell lymphoma through combined molecular dynamics simulation, molecular docking and QSAR techniques and design of new inhibitors

  2019cites this paper
• Synthesis of Chiral Tertiary α,α-Difluoromethyl Carbinols by Cu-Catalyzed Asymmetric Propargylation.

  2019cites this paper
• Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors.

  2019cites this paper
• Organo‐ and Copper‐Multi‐Catalyzed Pseudo Four‐Component Access to gem‐Difluorohydrins

  2018cites this paper
• Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.

  2018cites this paper
• First report on 3D-QSAR and molecular dynamics based docking studies of GCPII inhibitors for targeted drug delivery applications

  2018cites this paper
• Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.

  2017cites this paper
• Bicatalyzed Three-Component Stereoselective Decarboxylative Fluoro-Aldolization for the Construction of Elongated Fluorohydrins

  2017cites this paper
• Enantioselective aldol reactions with masked fluoroacetates.

  2016cites this paper
• In Silico Exploration of 1,7-Diazacarbazole Analogs as Checkpoint Kinase 1 Inhibitors by Using 3D QSAR, Molecular Docking Study, and Molecular Dynamics Simulations

  2016cites this paper
• 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer.

  2016cites this paper
• Synthesis, antiviral activity, 3D-QSAR, and interaction mechanisms study of novel malonate derivatives containing quinazolin-4(3H)-one moiety.

  2016cites this paper
• Molecular modeling studies of [6,6,5] Tricyclic Fused Oxazolidinones as FXa inhibitors using 3D-QSAR, Topomer CoMFA, molecular docking and molecular dynamics simulations.

  2015cites this paper
• Pharmacodynamics and potential synergistic effects of Mai-Luo-Ning injection on cardiovascular protection, based on molecular docking.

  2015cites this paper
• 5位取代的4,4-二氟-3,5-二羟基羧酸及其金属盐的制备方法

  2014cites this paper
• Method for preparing 5-substituted 4,4-difluoro-3,5-dihydrocarboxylic acid and metal salts thereof

  2014cites this paper